Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (600)	2/19/1999 4:08:00 AM
From: Mike McFarland	Respond to of 1073

IND filings are possible for rhGGF2 for these indications... multiple sclerosis muscle wasting muscle injury peripheral neuropathies myasthenia gravis muscular dystrophies spinal cord injuries nerve regeneration diabetic neuropathy chemo-induced neuropathies cancer: breast, ovarian, brain I don't know how that last one showed up on the list...maybe it is an error. This is obviously a big grab bag, and how recap got those entries I have no idea. Soon shareholders of Cambridge NeuroScience should have one of those half-yearly letters in our hands, and then it will be a lot easier to speculate on which goes off first, probably MS. If CNSI should need delivery beyond the blood/brain barrier, maybe they can team up with my #2 pick, ctii for their encapsulation technology, neuro CRIB I think it is named...but this is darts again. (and your points on the CytoTherapeutics thread were not lost on me...however, Cyto has managed to accumulate scores of patents, so who knows?) So, to answer your question...I do not think that Alzheimer's dementia or Parkinson's disease is on CNSI's list. Also, I know I am very early jumping on CNSI, but I have a thing about getting in super cheap. I will grow out of this condition in time. I suppose the time to really load up is after a lot more mice are sacrificed and CNSI shows up on the FDA server. Up all night with new eyeglasses, and headed for the tallest pile on my desk now! --Mike